MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    The relationship between dimensions of mental health and markers of Parkinson’s disease risk in the UK Biobank

    B. Attaallah, S. Waters, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: To investigate the relationship between indicators of mental health, and neuroimaging and genetic markers of Parkinson’s disease (PD). Background: PD is associated with a…
  • 2024 International Congress

    Distress Tolerance in Patients with Tremor Disorders

    P. Sheehan, K. Pyle, M. Coleman, D. Sblendorio, D. Talkington, Y. Deng, A. Murray, A. Memon, N. Jasinski, M. Moreno-Escobar, J. Frey (Morgantown, USA)

    Objective: To examine the relationship of distress tolerance and symptom manifestation in patients with functional movement disorder(FMD), Parkinson’s disease(PD), and essential tremor(ET). Background: Patients with…
  • 2024 International Congress

    Complete Resolution of Tardive Dystonia After Bilateral Globus Pallidus Interna Deep Brain Stimulation

    L. Okar, P. Murin, C. Pratap (St.Louis, USA)

    Objective: To share an exciting case of a young lady with disabling generalized Tardive Dystonia (TD) with complete resolution of symptoms following bilateral Globus pallidus…
  • 2024 International Congress

    Systematic Review and Meta-Analysis of Pesticide Exposure and the Risk of Parkinson’s Disease

    J. Cheong, ZHK. Goh, H. Frankland, S. Spearman, J. Steinmetz, A. Noyce (London, United Kingdom)

    Objective: This study aimed to investigate the association between exposure to pesticides and the risk of Parkinson’s disease (PD). Background: PD is the second most…
  • 2024 International Congress

    PREVENT-PD: A Framework for Collecting Trichloroethylene Contamination Data in New York State

    M. Pawlik, K. Hylton, S. Hussain, M. Piraino, D. Kinel, R. Dorsey (Rochester, USA)

    Objective: To describe methodology used to collect data on trichloroethylene (TCE) and perchloroethylene (PCE) contamination in Monroe County, New York. Background: TCE and PCE, chlorinated…
  • 2024 International Congress

    Global Trend of Parkinson’s Disease in 38 OECD Countries from 1990-2019: An Insight from the GBD 2019.

    H. Desai, H. Chhayani, N. Brahmbhatt, J. Jobby, B. Desai, M. Lakkimsetti, P. Vemparala (Bhuj, India)

    Objective: The focus of this study was to assess the burden of PD in the organization for economic cooperation and development (OECD) region from 1990-2019.…
  • 2024 International Congress

    Movement Disorder Society Unified Parkinson’s Disease Rating Scale Motor Examination Retains Its 2-Domain Profile in Both On and Off States

    T. Mestre, G. Stebbins, C. Goetz, S. Luo (Ottawa, Canada)

    Objective: This study aims to validate the two-domain structure of MDS-UPDRS Part III items in both medication states, exploring the discriminative ability of the tremor…
  • 2024 International Congress

    Touchscreen performance in people with Parkinson’s Disease

    N. Cohen, R. Kizony (Haifa, Israel)

    Objective: To investigate touchscreen performance and its associations with cognitive ability and upper limb (UL) function in people with Parkinson’s Disease (PWP). Background: Touchscreen use…
  • 2024 International Congress

    Virtual reality in patients with Hereditary Spastic Paraplegia

    M. Severiano, G. Dos Santos, C. de Araújo, F. Magno, B. Zeigelboim, H. Teive (Curitiba, Brazil)

    Objective: To assess the benefits of vestibular rehabilitation (VR) with virtual reality as a therapeutic tool in individuals with Hereditary Spastic Paraplegia (HSP), comparing two…
  • 2024 International Congress

    ProACT Study Protocol: a Randomized, Wait-list Controlled, Pragmatic Study on Parkinson’s Disease Multimodal Complex Treatment

    R. Scherbaum, E. Hinrichs, A. Horstmann, J. Schmidt-Fleischer, J. Stein, J. Geritz, J. Welzel, E. Kwon, J. Oppermann, V. Tschentscher, A. Mattukat, S. Muhlack, S. Faissner, C. Hansen, K. Winklhofer, R. Gold, W. Maetzler, N. Timmesfeld, L. Tönges (Bochum, Germany)

    Objective: To describe (1) the real-world effectiveness of the multidisciplinary inpatient rehabilitation (MIR) ‘Parkinson’s Disease Multimodal Complex Treatment’ (PD-MCT) in people with PD (PwP) compared…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley